EDIL3 was similarly enriched in SF EVs from RA joints with low‐level inflammation, than in RA joints with high‐level inflammation (10‐fold; adj. P‐value = 0.002), suggesting EDIL3 might also have chondroprotective effects in RA. Here, EDIL3 is linked to rheumatoid arthritis.